Published in Biol Psychiatry on January 05, 2012
Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression. J Neurosci (2013) 1.29
The interactive effects of estrogen and progesterone on changes in emotional eating across the menstrual cycle. J Abnorm Psychol (2012) 1.20
Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Front Neurosci (2015) 1.06
Sex differences and estrous cycle in female rats interact with the effects of fluoxetine treatment on fear extinction. Behav Brain Res (2013) 0.92
Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography. JAMA Psychiatry (2014) 0.92
5-HTTLPR X stress in adolescent depression: moderation by MAOA and gender. J Abnorm Child Psychol (2013) 0.84
Signaling mechanisms involved in the acute effects of estradiol on 5-HT clearance. Int J Neuropsychopharmacol (2014) 0.80
Effects of Long-Term Treatment with Estradiol and Estrogen Receptor Subtype Agonists on Serotonergic Function in Ovariectomized Rats. Neuroendocrinology (2015) 0.77
Influence of acute or chronic administration of ovarian hormones on the effects of desipramine in the forced swim test in female rats. Psychopharmacology (Berl) (2014) 0.75
Female reproductive life cycle and hormones: methodology to improve clinical trials. J Clin Psychiatry (2013) 0.75
Comparison of the Antidepressant-Like Effects of Estradiol and That of Selective Serotonin Reuptake Inhibitors in Middle-Aged Ovariectomized Rats. Front Aging Neurosci (2016) 0.75
Mifepristone modulates serotonin transporter function. Neural Regen Res (2014) 0.75
Increased Serum G Protein-coupled Estrogen Receptor 1 Levels and Its Diagnostic Value in Drug Naïve Patients with Major Depressive Disorder. Clin Psychopharmacol Neurosci (2017) 0.75
Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A (1996) 10.94
Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther (1977) 8.46
Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol (2000) 5.53
Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol (1997) 5.43
Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol (2006) 5.20
Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology (2004) 5.20
Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci (2002) 4.02
Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol (2002) 3.65
Estrogen actions in the central nervous system. Endocr Rev (1999) 3.64
Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol (2005) 3.44
Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem (2000) 3.34
Estrogen actions throughout the brain. Recent Prog Horm Res (2002) 3.17
The ABCs of depression: integrating affective, biological, and cognitive models to explain the emergence of the gender difference in depression. Psychol Rev (2008) 2.74
Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics (1997) 2.28
Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J Endocrinol (2007) 2.20
Progesterone receptors: form and function in brain. Front Neuroendocrinol (2008) 2.15
Uncovering the mechanisms of estrogen effects on hippocampal function. Front Neuroendocrinol (2007) 2.13
Estrous cycle and sex differences in performance on anxiety tasks coincide with increases in hippocampal progesterone and 3alpha,5alpha-THP. Pharmacol Biochem Behav (2000) 2.08
Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta. Endocrinology (1999) 1.93
G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem Biophys Res Commun (2006) 1.79
Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berl) (1999) 1.76
ERbeta-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariectomized rats. Neuropsychopharmacology (2005) 1.61
GPR30: A G protein-coupled receptor for estrogen. Mol Cell Endocrinol (2007) 1.59
Estrogen receptors outside the nucleus in breast cancer. Breast Cancer Res Treat (2007) 1.54
Estrogen-induced plasticity from cells to circuits: predictions for cognitive function. Trends Pharmacol Sci (2009) 1.47
Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci (1999) 1.42
Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry (1998) 1.40
Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin. J Cell Physiol (2006) 1.36
Effect of estrogen-serotonin interactions on mood and cognition. Behav Cogn Neurosci Rev (2005) 1.34
Cloning of the human oestrogen receptor cDNA. J Steroid Biochem (1986) 1.31
Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry (2004) 1.31
17 Beta-estradiol-induced antidepressant-like effect in the forced swim test is absent in estrogen receptor-beta knockout (BERKO) mice. Psychopharmacology (Berl) (2005) 1.27
Implications of adult hippocampal neurogenesis in antidepressant action. J Psychiatry Neurosci (2004) 1.24
Antidepressant effects of ERbeta-selective estrogen receptor modulators in the forced swim test. Pharmacol Biochem Behav (2004) 1.22
Expression and intracellular distribution of the G protein-coupled receptor 30 in rat hippocampal formation. Neurosci Lett (2008) 1.19
Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology (2004) 1.19
Extra-nuclear estrogen receptor GPR30 regulates serotonin function in rat hypothalamus. Neuroscience (2008) 1.17
Estradiol or diarylpropionitrile decrease anxiety-like behavior of wildtype, but not estrogen receptor beta knockout, mice. Behav Neurosci (2008) 1.16
Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter. Curr Med Chem (2008) 1.15
Antidepressant-like effect of different estrogenic compounds in the forced swimming test. Neuropsychopharmacology (2003) 1.14
The roles of membrane estrogen receptor subtypes in modulating dopamine transporters in PC-12 cells. J Neurochem (2008) 1.13
Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER. Prostaglandins Other Lipid Mediat (2009) 1.07
Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test. Eur J Pharmacol (2002) 1.07
Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci (2002) 1.06
Ovarian steroids and serotonin neural function. Mol Neurobiol (1998) 1.04
Sex differences in the regulation of progesterone receptor isoforms expression in the rat brain. Brain Res Bull (2002) 1.02
Antisense oligodeoxynucleotides for estrogen receptor-beta and alpha attenuate estradiol's modulation of affective and sexual behavior, respectively. Neuropsychopharmacology (2007) 1.02
Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am J Geriatr Psychiatry (1997) 1.02
Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways. J Soc Gynecol Investig (2000) 1.01
Depression during menopausal transition: a review of treatment strategies and pathophysiological correlates. Menopause Int (2008) 0.97
Ethopharmacology of imipramine in the forced-swimming test: gender differences. Neurosci Biobehav Rev (1998) 0.96
Changes in progesterone receptor isoforms content in the rat brain during the oestrous cycle and after oestradiol and progesterone treatments. J Neuroendocrinol (2003) 0.96
Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. Am J Geriatr Psychiatry (2001) 0.96
Sexual and psychological symptoms in the climacteric years. Maturitas (2006) 0.96
Impact of ovarian hormones on the modulation of the serotonin transporter by fluvoxamine. Neuropsychopharmacology (2008) 0.95
Progestin receptor-mediated reduction of anxiety-like behavior in male rats. PLoS One (2007) 0.94
Ultrastructural localization of extranuclear progestin receptors in the rat hippocampal formation. J Comp Neurol (2008) 0.94
Interaction between estrogens and antidepressants in the forced swimming test in rats. Psychopharmacology (Berl) (2004) 0.94
Progesterone and progestins: effects on brain, allopregnanolone and beta-endorphin. J Steroid Biochem Mol Biol (2006) 0.94
Response to SSRIs and role of the hormonal therapy in post-menopausal depression. Eur Neuropsychopharmacol (2006) 0.92
Ovarian steroid action in the serotonin neural system of macaques. Novartis Found Symp (2000) 0.92
The effect of estradiol in the striatum is blocked by ICI 182,780 but not tamoxifen: pharmacological and behavioral evidence. Neuroendocrinology (2003) 0.92
In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters. J Pharmacol Exp Ther (1998) 0.91
Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain. Neuropsychopharmacology (2000) 0.91
Antidepressant-like actions of pregnancy, and progesterone in Wistar rats forced to swim. Psychoneuroendocrinology (2001) 0.87
Membrane sex-steroid receptors in the brain. Front Neuroendocrinol (1996) 0.87
Influence of brain-derived neurotrophic factor (BDNF) on serotonin neurotransmission in the hippocampus of adult rodents. Eur J Pharmacol (2008) 0.87
Hormones and depression: what are the facts about premenstrual syndrome, menopause, and hormone replacement therapy? Am J Obstet Gynecol (1995) 0.86
The effects of estradiol on central serotonergic systems and its relationship to mood in women. Biol Res Nurs (2007) 0.85
Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord (1999) 0.84
Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain. Neurosci Lett (2007) 0.84
Regulation of high-affinity GABAA receptors in the dorsal hippocampus by estradiol and progesterone. Brain Res (1989) 0.83
Progesterone regulation of synaptic transmission and plasticity in rodent hippocampus. Learn Mem (2008) 0.82
The steroid hormone antagonist RU486. Mechanism at the cellular level and clinical applications. Endocrinol Metab Clin North Am (1991) 0.82
Estradiol rapidly induces the translocation and activation of the intermediate conductance calcium activated potassium channel in human eccrine sweat gland cells. Steroids (2008) 0.82
Cell surface localization of a novel non-genomic progesterone receptor on the head of human sperm. Biochem Biophys Res Commun (1991) 0.81
Depression during the menopausal transition: window of vulnerability or continuum of risk? Menopause (2008) 0.80
Gonadal steroids, selective serotonin reuptake inhibitors, and mood disorders in women. Med Clin North Am (2003) 0.78
VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology (2006) 2.24
Leptin: a potential novel antidepressant. Proc Natl Acad Sci U S A (2006) 2.15
Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment. Neuropsychopharmacology (2007) 1.61
Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. Int J Neuropsychopharmacol (2004) 1.42
Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology (2004) 1.38
Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry. J Neurosci Methods (2005) 1.14
Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci (2002) 1.06
Vagal nerve stimulation rapidly activates brain-derived neurotrophic factor receptor TrkB in rat brain. PLoS One (2012) 1.03
Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine. Int J Neuropsychopharmacol (2000) 0.98
Selective decreases in amphetamine self-administration and regulation of dopamine transporter function in diabetic rats. Neuroendocrinology (2003) 0.96
Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats. Biol Psychiatry (2011) 0.96
Impact of ovarian hormones on the modulation of the serotonin transporter by fluvoxamine. Neuropsychopharmacology (2008) 0.95
Induction of c-Fos and DeltaFosB immunoreactivity in rat brain by Vagal nerve stimulation. Neuropsychopharmacology (2007) 0.95
CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum. J Neurochem (2007) 0.95
Resolving the onset of antidepressants' clinical actions: critical for clinical practice and new drug development. J Clin Psychopharmacol (2006) 0.93
Regulation of the norepinephrine transporter by chronic administration of antidepressants. Biol Psychiatry (2004) 0.93
A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters. Biol Psychiatry (2005) 0.91
Rethinking depression and the actions of antidepressants: uncovering the links between the neural and behavioral elements. J Affect Disord (2010) 0.90
Influence of brain-derived neurotrophic factor (BDNF) on serotonin neurotransmission in the hippocampus of adult rodents. Eur J Pharmacol (2008) 0.87
Effects of chronic plus acute prolonged stress on measures of coping style, anxiety, and evoked HPA-axis reactivity. Neuropharmacology (2012) 0.86
Serotonin (5-HT) transporter (SERT) function after graded destruction of serotonergic neurons. J Neurochem (2003) 0.82
Enhancing the technology of clinical trials and the trials model to evaluate newly developed, targeted antidepressants. Neuropsychopharmacology (2002) 0.82
[(3)H] citalopram binding to serotonin transporter sites in minnow brains. Basic Clin Pharmacol Toxicol (2007) 0.81
Exogenous prenatal corticosterone exposure mimics the effects of prenatal stress on adult brain stress response systems and fear extinction behavior. Psychoneuroendocrinology (2013) 0.81
Regulatory effects of reboxetine treatment alone, or following paroxetine treatment, on brain noradrenergic and serotonergic systems. Neuropsychopharmacology (2003) 0.80
Differential in vivo clearance of serotonin in rat dorsal raphe nucleus and CA3 region. Brain Res (2002) 0.79
A multivantaged behavioural method for measuring onset and sequence of the clinical actions of antidepressants. Int J Neuropsychopharmacol (2004) 0.78
Comparison of ΔFosB immunoreactivity induced by vagal nerve stimulation with that caused by pharmacologically diverse antidepressants. J Pharmacol Exp Ther (2012) 0.78
Effects of Long-Term Treatment with Estradiol and Estrogen Receptor Subtype Agonists on Serotonergic Function in Ovariectomized Rats. Neuroendocrinology (2015) 0.77
Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain. Biol Psychiatry (2006) 0.77
Influence of acute or chronic administration of ovarian hormones on the effects of desipramine in the forced swim test in female rats. Psychopharmacology (Berl) (2014) 0.75
The International Journal of Neuropsychopharmacology. Int J Neuropsychopharmacol (1998) 0.75
The componential approach enhances the effectiveness of 2-week trials for new antidepressants. J Clin Psychopharmacol (2011) 0.75
Preclinical models of schizophrenia. Int J Neuropsychopharmacol (2013) 0.75
Evidence for shortening the duration of clinical trials of antidepressants and a proposed paradigm for such studies. J Clin Psychopharmacol (2015) 0.75
A video method for the evaluation of antidepressant clinical and behavioural actions. Int J Neuropsychopharmacol (2005) 0.75